Effects of conventional CPB and mini-CPB on neutrophils CD162, CD166 and CD195 expression

被引:7
|
作者
Holmannova, Drahomira [1 ,2 ]
Kolackova, Martina [1 ,2 ]
Mandak, Jiri [2 ,3 ]
Kunes, Pavel [2 ,3 ]
Holubcova, Zdenka [2 ,3 ]
Holubec, Tomas [4 ]
Krejsek, Jan [1 ,2 ]
机构
[1] Charles Univ Prague, Fac Med, Dept Clin Immunol, Hradec Kralove, Czech Republic
[2] Univ Hosp, Hradec Kralove, Czech Republic
[3] Charles Univ Prague, Fac Med, Dept Cardiac Surg, Hradec Kralove, Czech Republic
[4] Univ Zurich Hosp, Div Cardiovasc Surg, Zurich, Switzerland
来源
PERFUSION-UK | 2017年 / 32卷 / 02期
关键词
cardiopulmonary bypass; inflammation; CD162; CD166; CD195; CELL-ADHESION MOLECULE; GLYCOPROTEIN LIGAND-1 PSGL-1; CARDIOPULMONARY BYPASS SYSTEM; CHEMOKINE RECEPTOR CCR5; P-SELECTIN; INFLAMMATORY RESPONSE; TYROSINE-PHOSPHORYLATION; EXTRACORPOREAL CIRCUIT; CARDIAC-SURGERY; UP-REGULATION;
D O I
10.1177/0267659116669586
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Cardiac surgery is known to trigger a systemic inflammatory response. While the use of conventional cardiopulmonary bypass (CPB) results in profound inflammation, modified mini-CPB is considered less harmful. We evaluated the impact of cardiac surgery on the expression of CD162, CD166, CD195 molecules and their association with the type of CPB used. Methods and Results: Twenty-four patients were enrolled in our study. Twelve of them were operated using conventional CPB while the other twelve patients underwent surgery with mini-CPB. Blood samples were analysed by flow cytometry. We observed a significant increase in median fluorescence intensity of CD162 and CD195 that peaked instantly after surgery and normalized to the baseline value on the 1(st) day post surgery, whereas CD166 was initially down-regulated and its median fluorescence intensity (MFI) value increased to the baseline in the next few days. Conclusion: We observed immediate changes in the expression of CD162, CD166, and CD195 molecules on the neutrophils after surgery in both study groups of patients. The intensity of the observed changes was significantly greater in the group of patients who underwent conventional CPB compared to patients who underwent mini-CPB cardiac surgery.
引用
收藏
页码:141 / 150
页数:10
相关论文
共 19 条
  • [1] Expression and Role of CD166 in the Chronic Kidney Disease
    Sun, Yan
    Wang, Yiping
    Cao, Qi
    Yu, Hong
    Zheng, Dong
    Wang, Ya
    Harris, David C. H.
    IRANIAN JOURNAL OF PEDIATRICS, 2015, 25 (05)
  • [2] Clinical Implication of CD166 Expression in Gastric Cancer
    Ishigami, Sumiya
    Ueno, Shinichi
    Arigami, Takaaki
    Arima, Hideo
    Uchikado, Yasuto
    Kita, Yoshiaki
    Sasaki, Ken
    Nishizono, Yuka
    Omoto, Itaru
    Kurahara, Hiroshi
    Matsumoto, Masataka
    Kijima, Yuko
    Natsugoe, Shoji
    JOURNAL OF SURGICAL ONCOLOGY, 2011, 103 (01) : 57 - 61
  • [3] ALCAM (CD166) Expression and Serum Levels in Pancreatic Cancer
    Tachezy, Michael
    Zander, Hilke
    Marx, Andreas H.
    Stahl, Phillip R.
    Gebauer, Florian
    Izbicki, Jakob R.
    Bockhorn, Maximilian
    PLOS ONE, 2012, 7 (06):
  • [4] Clinical implication of CD166 expression in salivary gland tumor
    Andisheh-Tadbir, Azadeh
    Ashraf, Mohammad Javad
    Khademi, Bijan
    Ahmadi, Shahab
    TUMOR BIOLOGY, 2015, 36 (04) : 2793 - 2799
  • [5] Effect of EpCAM, CD44, CD133 and CD166 expression on patient survival in tumours of the ampulla of Vater
    Piscuoglio, Salvatore
    Lehmann, Frank S.
    Zlobec, Inti
    Tornillo, Luigi
    Dietmaier, Wolfgang
    Hartmann, Arndt
    Wuensch, Peter H.
    Sessa, Fausto
    Ruemmele, Petra
    Baumhoer, Daniel
    Terracciano, Luigi M.
    JOURNAL OF CLINICAL PATHOLOGY, 2012, 65 (02) : 140 - 145
  • [6] Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients
    Donizy, Piotr
    Zietek, Marcin
    Halon, Agnieszka
    Leskiewicz, Marek
    Kozyra, Cyprian
    Matkowski, Rafal
    DIAGNOSTIC PATHOLOGY, 2015, 10
  • [7] CD166/ALCAM Mediates Proinflammatory Effects of S100B in Delayed Type Hypersensitivity
    von Bauer, Ruediger
    Oikonomou, Dimitrios
    Sulaj, Alba
    Mohammed, Sawsan
    Hotz-Wagenblatt, Agnes
    Groene, Hermann-Josef
    Arnold, Bernd
    Falk, Christine
    Luethje, Dorit
    Erhardt, Axel
    Stern, David M.
    Bierhaus, Angelika
    Nawroth, Peter P.
    JOURNAL OF IMMUNOLOGY, 2013, 191 (01) : 369 - 377
  • [8] ALCAM (CD166) Expression as Novel Prognostic Biomarker for Pancreatic Neuroendocrine Tumor Patients
    Tachezy, Michael
    Zander, Hilke
    Marx, Andreas H.
    Gebauer, Florian
    Rawnaq, Tamina
    Kaifi, Jussuf T.
    Sauter, Guido
    Izbicki, Jakob R.
    Bockhorn, Maximilian
    JOURNAL OF SURGICAL RESEARCH, 2011, 170 (02) : 226 - 232
  • [9] Expression and function of P-selectin glycoprotein ligand 1 (CD162) on human basophils
    Taylor, ML
    Brummet, ME
    Hudson, SA
    Miura, K
    Bochner, BS
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 106 (05) : 918 - 924
  • [10] ALCAM (CD166) expression and serum levels are markers for poor survival of esophageal cancer patients
    Tachezy, Michael
    Effenberger, Katharina
    Zander, Hilke
    Minner, Sarah
    Gebauer, Florian
    Vashist, Yogesh K.
    Sauter, Guido
    Pantel, Klaus
    Izbicki, Jakob R.
    Bockhorn, Maximilian
    INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (02) : 396 - 405